NexgenRx Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CAD 2.761 million compared to CAD 2.405 million a year ago. Net income was CAD 380,106 compared to CAD 479,104 a year ago. Basic earnings per share from continuing operations was CAD 0.005 compared to CAD 0.007 a year ago. For the half year, total revenue was CAD 5.564 million compared to CAD 5.279 million a year ago. Net income was CAD 742,217 compared to CAD 763,695 a year ago. Basic earnings per share from continuing operations was CAD 0.011 compared to CAD 0.011 a year ago.